Mayflower Financial Advisors, LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1852930 BOSTON, MA

Position in INO

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$13,814

-$8,038 QoQ

Shares Held

12,559

0.0% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 102 holders

Holding Since

Dec 2020

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Mayflower Financial Advisors, LLC holds $1,390,659 across 8 Biotechnology names. INO ranks #6 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,681	$835,003
2	GLUE	Monte Rosa Therapeutics, Inc.	10,000	$242,000
3	IBRX	ImmunityBio, Inc.	20,212	$176,956
4	HELP	Cybin Inc.	10,290	$68,016
5	ELTX	Elicio Therapeutics, Inc.	10,000	$39,100
6	INO	Inovio Pharmaceuticals, Inc. This page	12,559	$13,814
7	GNPX	Genprex, Inc.	909	$10,380
8	GTBP	GT Biopharma, Inc.	11,000	$5,390

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,814	12,559	0.0%	Shares	Sole	2026-07-09
2026-03-31	$21,852	12,559	0.0%	Shares	Sole	2026-04-23
2025-12-31	$21,852	12,559	-59.4%	Shares	Sole	2026-01-13
2023-12-31	$15,786	30,953	0.0%	Shares	Sole	2024-01-22
2023-09-30	$12,071	30,953	0.0%	Shares	Sole	2023-10-12
2023-06-30	$13,928	30,953	0.0%	Shares	Sole	2023-07-13
2023-03-31	$25,381	30,953	0.0%	Shares	Sole	2023-04-12
2022-12-31	$48,286	30,953	0.0%	Shares	Sole	2023-01-25
2022-09-30	$53,548	30,953	0.0%	Shares	Sole	2022-10-19
2022-06-30	$53,548	30,953	0.0%	Shares	Sole	2022-07-15
2022-03-31	$111,121	30,953	+1.3%	Shares	Sole	2022-04-21
2021-12-31	$152,434	30,548	-1.0%	Shares	Sole	2022-01-21
2021-09-30	$220,828	30,842	0.0%	Shares	Sole	2021-10-26
2021-06-30	$285,905	30,842	+1.4%	Shares	Sole	2021-07-29
2021-03-31	$282,130	30,402	+4.6%	Shares	Sole	2021-04-23
2020-12-31	$257,322	29,076	—	Shares	Sole	2021-04-12
No filing history on record for this holder in this stock.